Targeted Disease(s):
Lung Cancer
Purpose of Study:
Squamous cell lung cancer. Lung-MAP is a multi-arm trial designed to test several different therapies simultaneously. MEDI4736, GDC-0032, Palbociclib, and AZD4547 are currently being studied, but the trial protocol could allow new therapies to be added in the future.
Study Dates:
June 16, 2014 - January 1, 2022
Study Location:
Nationwide